TAMELA MATTHEWS: Open Payments
NPI 1235547589 · SMACKOVER, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 12 payments from 4 companies in 2025. Trend: 2023 $77 · 2024 $250 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $106 |
| E.R. Squibb & Sons, L.L.C. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Alkermes, Inc. | 1 | $16 |
Products named: INGREZZA, COBENFY, REXULTI, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across AR — which companies pay providers there.
